NCT04720976 2025-04-11
JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors
Allist Pharmaceuticals, Inc.
Phase 1/2 Completed
Clinical Trials
4 trialsNCT03861156 2024-04-09
D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer
InventisBio Co., Ltd
Phase 2 Completed
NCT02959619 2023-08-21
Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALK
Betta Pharmaceuticals Co., Ltd.
Phase 1 Completed
NCT02423343 2021-09-09
A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma
Eli Lilly and Company
Phase 1/2 Completed